“Drugs companies publish only a fraction of their results and keep much of the information to themselves, but regulators want to ban the practice. If companies published all of their clinical trials data, independent scientists could reanalyse their results and check companies’ claims about the safety and efficacy of drugs. Under proposals being thrashed out in Europe, drugs companies would be compelled to release all of their data, including results that show drugs do not work or cause dangerous side-effects. The latest strategy shows how patient groups – many of which receive some or all of their funding from drugs companies – have been brought into the battle.”
(Visited 34 times, 1 visits today)
Related posts:
GCHQ taps fibre-optic cables for secret access to world's communications, shares with NSA
U.S. chooses Afghanistan for first "mother of all bombs" drop
Mexico says marijuana legalization in U.S. could change anti-drug strategies
Justin Amash: Obama 'Highly Misleading' In Claiming No Domestic Spying Program
Caught On Camera: Woman Goes Into Cardiac Arrest During Traffic Stop
Pennsylvania tax collector sold weed outside courthouse
Arkansas to vote on legalizing medical marijuana in November
UN group warns of ‘significant’ cybersecurity vulnerabilities in mobile phone technology
Canada’s first blockchain ETF approved
Victims of Police Beat-down Say Video Proves Brutality
McCain calls Paul, Cruz, Amash ‘wacko birds’ after CIA director filibuster
NYPD chief Ray Kelly defends officers over Empire State Building shooting
Florida housing market may get a boost from ‘boomerang buyers’
Former President Bush praises President Obama on counterterrorism and immigration reform
Obama renewing call to reauthorize Export-Import Bank